Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Upstream Bio, Inc. (UPB) had Normalized Income after Taxes of $-40.59M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.03M |
|
$-40.59M |
|
-- |
|
$1.03M |
|
$44.65M |
|
$-43.62M |
|
$3.02M |
|
$-40.59M |
|
$-40.59M |
|
$-40.59M |
|
$-40.59M |
|
$-40.59M |
|
|
Normalized Income after Taxes |
$-40.59M |
$-43.62M |
|
$-44.32M |
|
54.33M |
|
54.33M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$316.28M |
|
$0.51M |
|
$1.77M |
|
$318.05M |
|
$13.67M |
|
-- |
|
$0.39M |
|
$14.06M |
|
$304.00M |
|
$304.00M |
|
$304.00M |
|
54.42M |
|
| Cash Flow Statement Financials | |
$-47.85M |
|
$42.40M |
|
$0.60M |
|
$101.77M |
|
$96.92M |
|
$-4.85M |
|
$4.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4218.09% |
|
-4218.09% |
|
-- |
|
-3925.63% |
|
-3925.63% |
|
$-47.85M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.00 |
|
90.00 |
|
-13.35% |
|
-13.35% |
|
-12.76% |
|
-13.35% |
|
$5.59 |
|
$-0.88 |
|
$-0.88 |
|